Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
21133
Cancer Research UK - United Kingdom
MC_U137686858
Medical Research Council - United Kingdom
C8225/A21133
Cancer Research UK - United Kingdom
RE/13/1/30181
British Heart Foundation - United Kingdom
PubMed
28943076
DOI
10.1016/j.ijrobp.2017.05.004
PII: S0360-3016(17)30901-X
Knihovny.cz E-resources
- MeSH
- Radiotherapy Dosage MeSH
- Diabetes Mellitus etiology MeSH
- Gastrointestinal Neoplasms etiology MeSH
- Hodgkin Disease radiotherapy MeSH
- Hypothyroidism etiology MeSH
- Organs at Risk radiation effects MeSH
- Humans MeSH
- Lung Neoplasms etiology MeSH
- Breast Neoplasms etiology MeSH
- Neoplasms, Radiation-Induced etiology MeSH
- Lymphoma, Non-Hodgkin radiotherapy MeSH
- Proton Therapy adverse effects MeSH
- Neoplasms, Second Primary etiology MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Department of Oncology University of Turin Turin Italy
Department of Radiation Oncology Emory University School of Medicine Atlanta Georgia
Department of Radiation Oncology Institut Curie Paris France
Department of Radiation Oncology Mayo Clinic Arizona Scottsdale Arizona
Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York
Department of Radiation Oncology Stanford University Stanford California
Department of Radiation Oncology University of Maryland School of Medicine Baltimore Maryland
Department of Radiation Oncology University of Pennsylvania Philadelphia Pennsylvania
Miami Cancer Institute at Baptist Health South Florida Miami Florida
Northwestern Medicine Chicago Proton Center Warrenville Illinois
Nuffield Department of Population Health University of Oxford Oxford UK
Proton Therapy Department Proton Therapy Center Prague Czech Republic
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey
References provided by Crossref.org
Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
